Biomagnetic Characterization of Gastric Dysrhythmias:Study 2

Ischemia Clinical Trial

— SQUID  

Official title:

Biomagnetic Characterization of Gastric Dysrhythmias:Study 2

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00178984
• Other study ID #: 051175
• Secondary ID: 5R01DK058697
• Status: Completed
• Phase: N/A
• First received: September 13, 2005
• Last updated: April 5, 2017
• Start date: June 2000
• Est. completion date: August 10, 2012

Study information

• Verified date: April 2017
• Source: Vanderbilt University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to use the Squid magnetometer (Superconducting QUantum Interference Device) to help diagnose electrical and mechanical abnormalities of the stomach and intestines.

Description:

The Squid magnetometer is a non-invasive investigational device that measures the electrical activity in the smooth muscle of the intestines. Volunteers with normal bowel activity, those with gastric problems, and diabetics with gastric problems will be studied under the SQuid to determine normal and abnormal activity. Diabetics with an abnormal gastric emptying study will be asked to participate.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: August 10, 2012
• Est. primary completion date: August 10, 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years to 65 Years

Eligibility

Inclusion Criteria:

• Normal volunteers, those with stomach problems, and Diabetics with abnormal gastric emptying study

Exclusion Criteria:

• Diabetics with a normal gastric emptying study

• Participants with claustrophobia

Related Conditions & MeSH terms

• Arrhythmias, Cardiac
• Ischemia

Locations

Country	Name	City	State
United States	Vanderbilt University Medical Center	Nashville	Tennessee

Sponsors (2)

Lead Sponsor	Collaborator
Vanderbilt University Medical Center	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	to observe a difference in the magnetic activity between the normal and diseased smooth muscle of the stomach and intestines.		2010
Secondary	to specifically study the electrical activity of diabetics with an abnormal gastric emptying.		2010
Secondary	Measurement of mesenteric ischemia		2010